Webhaber
Humira Faces Competition From First U.S. Copycat

Humira Faces Competition From First U.S. Copycat

The arthritis therapy is coming up against its first so-called biosimilar, after more than $135 billion in sales and fights over how long its patents last.

Wall Street Journal Wall Street Journal | Go to detail of news source

Wall Street Journal, Benzer haberler

Wall Street Journal Microsoft Earnings Likely Slid Last Quarter Amid Economic Concerns Microsoft Earnings Likely Slid Last Quarter Amid Economic Concerns
Wall Street Journal Mexico Bans Climate Startup's Experiments to Cool the Earth Mexico Bans Climate Startup's Experiments to Cool the Earth
Wall Street Journal Twitter Hasn't Paid Bill, M&A Advisory Firm Says Twitter Hasn't Paid Bill, M&A Advisory Firm Says
Wall Street Journal Gucci Parent Kering Taps Estee Lauder Executive for Beauty Push Gucci Parent Kering Taps Estee Lauder Executive for Beauty Push
Wall Street Journal Google Case Heads to Supreme Court With Powerful Internet Law at Stake Google Case Heads to Supreme Court With Powerful Internet Law at Stake
Wall Street Journal Amazon Poised to Post Slowest Sales Growth in Decades Amazon Poised to Post Slowest Sales Growth in Decades